{"id":"https://openalex.org/W2185199635","doi":"https://doi.org/10.1158/1538-7445.am2015-275","title":"Abstract 275: ER-886046, an antagonist of PGE2 receptor type-4, induces an effective antitumor immune response in mice by attenuating intratumoral MDSCs and TAMs","display_name":"Abstract 275: ER-886046, an antagonist of PGE2 receptor type-4, induces an effective antitumor immune response in mice by attenuating intratumoral MDSCs and TAMs","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2185199635","doi":"https://doi.org/10.1158/1538-7445.am2015-275","mag":"2185199635"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-275","doi":"https://doi.org/10.1158/1538-7445.am2015-275","is_oa":false,"landing_page_url":"http://doi.org/10.1158/1538-7445.am2015-275","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065592547","display_name":"Diana I. Albu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana I. Albu","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103164788","display_name":"Zichun Wang","orcid":"https://orcid.org/0000-0003-0849-3113","observed_orcids":["https://orcid.org/0000-0003-0849-3113"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zichun Wang","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jiayi Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiayi Wu","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198827","display_name":"Kuan\u2010Chun Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuan-chun Huang","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318370","display_name":"Wei Li","orcid":"https://orcid.org/0000-0003-1186-8609","observed_orcids":["https://orcid.org/0000-0003-1186-8609"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056820862","display_name":"Diana Liu","orcid":"https://orcid.org/0000-0002-1559-2622","observed_orcids":["https://orcid.org/0000-0002-1559-2622"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Liu","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021756014","display_name":"Galina Kuznetsov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Galina Kuznetsov","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qian Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qian Chen","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045462016","display_name":"Xingfeng Bao","orcid":"https://orcid.org/0000-0001-9309-8024","observed_orcids":["https://orcid.org/0000-0001-9309-8024"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xingfeng Bao","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057114998","display_name":"Mary Woodall-Jappe","orcid":"https://orcid.org/0000-0001-8213-7884","observed_orcids":["https://orcid.org/0000-0001-8213-7884"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Woodall-Jappe","raw_affiliation_strings":["Eisai, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Andover, MA","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210151718"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"275","last_page":"275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ep4-receptor-antagonist","display_name":"EP4 receptor antagonist","score":0.7910000085830688},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.8999999761581421},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6050000190734863},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8859999775886536},{"id":"https://openalex.org/keywords/monocyte-differentiation","display_name":"monocyte differentiation","score":0.7900000214576721},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.7609999775886536},{"id":"https://openalex.org/keywords/t-cell-dependent-immune-response","display_name":"T cell-dependent immunity","score":0.7689999938011169},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7059999704360962},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.5950000286102295},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8730000257492065},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6969131827354431},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6506543159484863},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.6088191270828247},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5653685927391052},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5054323673248291},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45812568068504333},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3781529366970062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37499117851257324},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3715195655822754},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35821691155433655},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.23313114047050476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19613227248191833}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-275","doi":"https://doi.org/10.1158/1538-7445.am2015-275","is_oa":false,"landing_page_url":"http://doi.org/10.1158/1538-7445.am2015-275","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391261506","https://openalex.org/W4389109455","https://openalex.org/W2727513755","https://openalex.org/W3083190503","https://openalex.org/W3137014047","https://openalex.org/W4254454265","https://openalex.org/W2764064910","https://openalex.org/W4416070411","https://openalex.org/W4313200212","https://openalex.org/W3011528702"],"abstract_inverted_index":{"Abstract":[0],"One":[1],"of":[2,5,13,40,58,90,105,119,124,140,224,267,288,293],"the":[3,11,38,51,56,101,122,218,289,294],"hallmarks":[4],"an":[6,87,131,265,272],"immunosuppressive":[7,173],"tumor":[8,52,61,96,128],"microenvironment":[9],"is":[10,34],"presence":[12],"myeloid-derived":[14],"suppressor":[15],"cells":[16,26],"(MDSCs)":[17],"and":[18,31,72,103,109,160,177,185,197,203,283],"type":[19,45,84,174],"2":[20,175],"tumor-associated":[21],"macrophages":[22,176],"(TAMs).":[23],"These":[24],"myeloid":[25],"derive":[27],"from":[28],"immature":[29],"monocytes":[30],"their":[32],"differentiation":[33,171,182],"highly":[35],"regulated":[36],"by":[37,228,279],"engagement":[39],"prostaglandin":[41],"E2":[42],"(PGE2)":[43],"receptor":[44,269],"4":[46],"(EP4)":[47],"with":[48,130,168],"PGE2":[49,268],"in":[50,67,82,150,158,161,200,215,238,277],"microenvironment.":[53],"To":[54],"understand":[55],"importance":[57],"EP4":[59,68,93,111,226],"for":[60,95,113,212,235,297],"support,":[62],"we":[63,99,156],"implanted":[64],"mouse":[65,126],"tumors":[66,76],"inducible":[69],"knockout":[70],"mice":[71,278],"found":[73,157],"that":[74,165],"these":[75],"grew":[77],"significantly":[78],"more":[79],"slowly":[80],"than":[81],"wild":[83],"mice,":[85,201],"indicating":[86],"important":[88],"role":[89],"host":[91],"cell":[92,152,189],"signaling":[94,227],"progression.":[97],"Here":[98],"report":[100],"development":[102],"evaluation":[104],"ER-886046,":[106,264],"a":[107,194,209,231],"novel":[108,232],"specific":[110],"antagonist,":[112],"cancer":[114,236],"treatment.":[115],"Daily":[116],"oral":[117],"administration":[118],"ER-886046":[120,141,166,192,229],"inhibited":[121],"growth":[123],"multiple":[125],"syngeneic":[127],"models":[129],"inhibitory":[132],"activity":[133,139],"up":[134],"to":[135],"100%.":[136],"The":[137],"anti-tumor":[138],"was":[142,147],"T":[143,151,188],"cell-dependent":[144],"since":[145],"it":[146,207],"not":[148],"observed":[149],"deficient":[153],"mice.":[154],"Furthermore,":[155],"vitro":[159],"vivo":[162],"mechanistic":[163],"evidence":[164],"interferes":[167],"tumor-induced":[169],"monocyte":[170,181],"into":[172,183],"MDSCs,":[178],"instead":[179],"supporting":[180],"APCs":[184],"facilitating":[186],"intratumoral":[187,281],"accumulation.":[190],"Importantly,":[191],"has":[193],"desirable":[195],"pharmacokinetic":[196],"metabolism":[198],"profile":[199],"rats":[202],"dogs":[204],"which":[205],"qualifies":[206],"as":[208,230],"good":[210],"candidate":[211],"clinical":[213,239],"studies":[214],"humans.":[216],"Thus,":[217],"preclinical":[219],"data":[220],"support":[221],"further":[222],"investigation":[223],"targeting":[225],"immune":[233,275],"therapy":[234],"treatment":[237],"setting.":[240],"Citation":[241],"Format:":[242],"Diana":[243,254],"I.":[244],"Albu,":[245],"Zichun":[246],"Wang,":[247],"Jiayi":[248],"Wu,":[249],"Kuan-chun":[250],"Huang,":[251],"Wei":[252],"Li,":[253],"Liu,":[255],"Galina":[256],"Kuznetsov,":[257],"Qian":[258],"Chen,":[259],"Xingfeng":[260],"Bao,":[261],"Mary":[262],"Woodall-Jappe.":[263],"antagonist":[266],"type-4,":[270],"induces":[271],"effective":[273],"antitumor":[274],"response":[276],"attenuating":[280],"MDSCs":[282],"TAMs.":[284],"[abstract].":[285],"In:":[286],"Proceedings":[287],"106th":[290],"Annual":[291],"Meeting":[292],"American":[295],"Association":[296],"Cancer":[298,308],"Research;":[299],"2015":[300],"Apr":[301],"18-22;":[302],"Philadelphia,":[303],"PA.":[304],"Philadelphia":[305],"(PA):":[306],"AACR;":[307],"Res":[309],"2015;75(15":[310],"Suppl):Abstract":[311],"nr":[312],"275.":[313],"doi:10.1158/1538-7445.AM2015-275":[314]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}